Institute for Molecular Bioscience (IMB)

Epilepsy Research

Epilepsy is the most common neurological disorder in children. Dravet syndrome is a rare but severe and incurable paediatric epilepsy that can cause significant developmental delays. Often beginning five-to-eight months after birth, seizures are typically frequent, unpredictable, and resistant to many anti-epileptic drugs. With your help, the King lab at IMB can advance research into a drug derived from spider venom that could restore function of neurons in the brain and eliminate seizures in people who have Dravet syndrome.

Support this potentially lifesaving research.